학술논문
Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results
Document Type
Article
Author
Lesokhin, A.M.; Tomasson, M.H.; Arnulf, B.; Bahlis, N.J.; Miles Prince, H.; Niesvizky, R.; Rodrίguez-Otero, P.; Martinez-Lopez, J.; Koehne, G.; Touzeau, C.; Jethava, Y.; Quach, H.; Depaus, J.; Yokoyama, H.; Gabayan, A.E.; Stevens, D.A.; Nooka, A.K.; Manier, S.; Raje, N.; Iida, S.; Raab, M.-S.; Searle, E.; Leip, E.; Sullivan, S.T.; Conte, U.; Czibere, A.; Elmeliegy, M.; Viqueira, A.; Mohty, M.
Source
In: Nature Medicine . (Nature Medicine, September 2023, 29(9):2259-2267)
Subject
Language
English
ISSN
1546170X
10788956
10788956